Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Recent filings | ||||||
Filed 2024-03-28 10:49 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+72,222 vol |
72,222 | |
Filed 2024-03-28 10:49 Tx date 2020-01-22 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-03-28 10:49 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-38,889 vol |
222,222 | |
Filed 2024-03-28 10:48 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-72,222 vol |
261,111 | |
Older filings | ||||||
Filed 2024-03-18 11:52 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+333,333 vol |
333,333 | |
Filed 2024-03-18 11:51 Tx date 2020-01-22 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-08-15 15:06 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
775,000 | |
Filed 2021-09-09 14:43 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
550,000 | |
Filed 2020-04-30 20:51 Tx date 2020-04-19 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
Filed 2020-04-30 15:56 Tx date 2020-01-22 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|